Molecular Imaging Products

Molecular Imaging Products. Shall mean products approved for sale by the appropriate U.S. and/or foreign regulatory body containing as the active ingredient the Company's radio-labeled molecular imaging agents, currently in development or developed by the Company in the future, including, without limitation, the ALTROPANE® and FLUORATEC molecular imaging agents, for the diagnosis and monitoring of Parkinson's Disease and Attention Deficit Hyperactivity Disorder using SPECT or PET camera imaging techniques.